Global Bone Void Fillers Market Size & Trends Report Segmented by Type (Demineralized Bone Matrix, Collagen Matrix), Form (Granules, Paste), Application (Spinal Fusion, Joint Reconstruction, Fracture), End User (Hospitals, ASCs) & Regional Forecast to 2031

The global bone void fillers market size is set to grow at 5% CAGR over the next 5 years. Rising incidence of orthopedic disorders and trauma cases, growth in geriatric population, advancements in biomaterials and tissue engineering, increasing number of spinal and joint replacement surgeries, shift towards minimally invasive procedures, and shortage and limitations of autografts/allografts are some of the key factors driving the growth of the global market. However, high cost of advanced bone void fillers, stringent regulatory approval processes, and limited osteoinductive capabilities are expected to impact the market’s growth.

Bone void fillers (BVFs) are biocompatible materials used to fill gaps or defects in bones resulting from trauma, surgery, disease, or congenital conditions. These fillers provide structural support and promote new bone growth by serving as scaffolds for osteogenesis. They are commonly used in orthopedic, spinal, dental, and trauma surgeries when natural bone grafts like autografts or allografts are not viable. BVFs can be made from various materials including synthetic substances like calcium phosphate, hydroxyapatite, allografts, or bioactive compounds. Their key advantages include reduced donor site morbidity, consistent availability, and the potential for customization to match patient-specific needs.

To learn more about this report, download the PDF brochure

Rising incidence of orthopedic disorders and trauma cases to propel market demand

The rising incidence of orthopedic disorders and trauma cases is significantly driving demand for bone void fillers (BVFs), as these conditions frequently result in bone defects requiring surgical reconstruction and effective bone-healing solutions. Conditions such as osteoporosis, osteoarthritis, bone tumours, and degenerative bone diseases, along with fractures caused by road accidents, workplace injuries, and sports-relatedtrauma, contribute to the growing volume of orthopedic and trauma procedures. According to The Lancet, approximately 494 million people worldwide were affected by musculoskeletal disorders in 2020, with this number projected to increase by 115% to approximately 1.06 billion by 2050. The growing burden of these conditions is expected to increase the number of surgical interventions involving bone repair and reconstruction.

BVFs are increasingly utilized to fill osseous defects, provide structural support, facilitate new bone formation, and promote defect healing across orthopedic, trauma, and spinal procedures. Their availability in various forms, including demineralized bone matrix, calcium-based materials, collagen matrices, and synthetic graft substitutes, enables clinicians to select products based on defect characteristics and procedural requirements. Furthermore, BVFs can supplement or serve as alternatives to autologous bone grafts, potentially reducing complications associated with graft harvesting. Consequently, increasing orthopedic disease prevalence, rising trauma burden, and expanding surgical treatment volumes are expected to sustain demand for BVFs globally.

Advancements in biomaterials and tissue engineering are driving the market growth

Advancements in biomaterials and tissueengineering are key drivers of growth in the bone void fillers (BVFs) market, enabling the development of products with improved biocompatibility, osteoconductivity, resorption characteristics, and mechanical performance. Innovations in synthetic materials such as calcium phosphate, hydroxyapatite, tricalcium phosphate, and bioactive glass are allowing manufacturers to develop fillers that more closely replicate the composition and functional characteristics of natural bone. These materials can provide structural support while gradually resorbing and facilitating new bone formation, making them suitable for a broad range of orthopedic, trauma, and spinal procedures.

In parallel, advances in tissue engineering and scaffoldtechnologies are supporting the development of three-dimensional structures with interconnected porous architectures that promote cellular infiltration, vascularization, and bone regeneration. Manufacturers are also exploring composite biomaterials that combine ceramics, polymers, collagen, and bioactive components to achieve a balance between mechanical strength and biological performance. Such innovations can improve handling characteristics and expand the applicability of BVFs to complex or irregular bone defects. The development of next-generation resorbable and bioactive fillers is also reducing reliance on traditional autografts in selected procedures, potentially minimizing donor-site complications. As clinical evidence and surgeon familiarity with these technologies increase, adoption of advanced BVFs is expected to expand, supporting market growth globally.

Customized and 3D-printed bone grafts, a major opportunity

Customized and 3D-printed bone grafts represent a promising opportunity in the bone void fillers market by enabling patient-specific solutions tailored to complex anatomical defects. Advanced 3D printing technologies can produce implants with customized shapes, porous structures, and controlled mechanical properties that support bone ingrowth and integration. These solutions may be particularly valuable in complex trauma, spinal, craniofacial, and revision orthopedic procedures where conventional fillers may not adequately address irregular defects. Growing adoption of digital imaging, computer-aided design, and additive manufacturing is facilitating personalized treatment approaches. Continued advances in biomaterials, combined with improving regulatory pathways and clinical evidence, are expected to create opportunities for wider commercialization of customized bone graft solutions.

To learn more about this report, download the PDF brochure

Type Segment Outlook

Demineralized Bone Matrix (DBM) accounts for the largest share of the bone void fillers market, supported by its strong osteoinductive and osteoconductive properties, biocompatibility, and established clinical use across orthopedic, trauma, and spinal procedures. DBM retains components of the natural bone matrix that support new bone formation and is available in convenient forms such as putty, paste, and gel, facilitating application in irregular defects. Its ability to provide an alternative to autografts while avoiding donor-site morbidity further supports adoption. Calcium sulfate is expected to register the fastest growth, driven by its predictable resorption, biocompatibility, and ability to completely biodegrade following bone regeneration. Its growing use as an antibiotic carrier in osteomyelitis and infection-related orthopedic procedures is further increasing demand. Rising adoption of synthetic bone void fillers and continued product launches are also supporting segment expansion.

Regional Outlook: North America maintains its leading position in the bone void fillers market

North America accounts for the largest share of the bone void fillers market, supported by its well-established orthopedic healthcare infrastructure, high volume of trauma, spinal fusion, joint reconstruction, and sports injury procedures, and strong adoption of advanced synthetic and bioactive bone substitutes. The region also benefits from the presence of leading manufacturers, established reimbursement pathways, and significant investment in clinical research and product development. Growing use of minimally invasive orthopedic procedures and surgeon preference for synthetic alternatives that can avoid complications associated with autograft harvesting further support demand. The US represents the major contributor to regional revenues, driven by its large procedural base and rapid adoption of innovative bone void filler technologies.

Asia Pacific is expected to register the fastest growth, driven by the increasing volume of orthopedic and trauma surgeries, rapidly aging populations, rising prevalence of osteoporosis, and expansion of healthcare infrastructure across China, India, Japan, and other markets. Growing awareness of bone void filler technologies and increasing adoption of advanced synthetic products are further supporting market development. In addition, rising healthcare expenditure, medical tourism, and increasing availability of specialized orthopedic care are expanding access to procedures requiring bone graft substitutes. The entry and expansion of manufacturers with cost-effective products are also expected to improve affordability and accelerate adoption across emerging APAC markets.

Competitive Landscape Analysis

The global bone void fillers market is marked by the presence of established and emerging market players such as-

• Medtronic
• Noraker
• Johnson & Johnson
• Stryker
• Baxter
• Bioventus
• Orthofix
• Bone Solutions Inc.
• OSferionBiomaterials Corp.
• Zimmer Biomet

Growth strategies adopted by players to establish their foothold in the bone void fillers market

Players operating in this market are adopting various growth strategies such as new product launch; acquisitions; expansions; and strategic partnerships, agreements, and collaborations, to garner market share. For instance,

• In June 2026, SDIP Innovations received FDA 510(k) clearance for JAZBI Bone Void Filler, a resorbable polymer-ceramic bone graft substitute designed to support tissue infiltration and new bone formation
• In August 2024, LifeNet Health launched PliaFX Pak in collaboration with Johnson & Johnson MedTech, a moldable bone allograft combining mineralized bone chips and demineralized fibers for orthopedic spine and trauma procedures
• In November 2024, NovaBone received FDA clearance for expanded use of NovaBone Putty in the intervertebral disc space, supporting interbody fusion procedures and broadening applications for synthetic bone void fillers
• In April 2023, Abyrx received additional FDA clearances for MONTAGE Settable Resorbable Bone Putty as a bone void filler and cranial bone cement, expanding its orthopedic and cranial applications

Report Scope

Market Segmentation

This report by Medi-Tech Insights provides the size of the global bone void fillers market at the regional and country-level from 2024 to 2031. The report further segments the market by type, form, application, and end user.

• Market Size & Forecast (2024-2031), By Type, USD Billion
• Demineralized Bone Matrix
• Calcium Sulfate
• Collagen Matrix
• Tricalcium phosphate
• Other Types

• Market Size & Forecast (2024-2031), By Form, USD Billion
• Granules
• Paste
• Putty
• Gels
• Other Forms

• Market Size & Forecast (2024-2031), By Application, USD Billion
• Spinal Fusion
• Joint Reconstruction
• Bone Fracture
• Other Applications

• Market Size & Forecast (2024-2031), By End User, USD Billion
• Hospitals and Clinics
• Orthopaedic Centers
• Ambulatory Surgical Centers (ASCs)
• Other End Users

• Market Size & Forecast (2024-2031), By Region, USD Billion
• North America
• US
• Canada
• Europe
• UK
• Germany
• France
• Italy
• Spain
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Rest of Asia Pacific
• Latin America
• Middle East & Africa